---

Liquid Oxygen (LOx) - A Note for MD Anaesthesia

---

Definition

---

Physical and Chemical Properties

Critical temperature (-119°C): This is the temperature below which oxygen can be liquefied by pressure alone. Above this temperature, no amount of pressure will liquefy oxygen. Therefore, LOx must be stored well below -119°C in insulated cryogenic containers. - Morgan & Mikhail's Clinical Anesthesiology, 7e

---

Why Liquid Rather Than Compressed Gas?

• Space efficiency: 1 litre of LOx produces ~840 litres of gaseous O₂ - far more compact than high-pressure cylinders
• Economics: More economical for large hospitals (lower cost per unit volume of oxygen delivered)
• Lower storage pressure: Stored at relatively low pressure compared to compressed gas cylinders (~2200 psig for E-cylinders)
• Fewer refills required: Bulk LOx tanks are refilled by tanker trucks on-site, reducing logistics burden
• Weight advantage: In portable systems (domiciliary), LOx reservoirs weigh less than equivalent compressed gas cylinders for the same oxygen content

---

Hospital Bulk LOx Supply System

Components:

1. Cryogenic bulk storage tank (Dewar vessel)
   • Double-walled construction with vacuum insulation between inner and outer walls (similar to a Thermos flask)
   • Maintains LOx at approximately -183°C
   • Typical hospital tanks hold thousands of litres of LOx
   • Refilled on-site from a tanker truck
2. Vaporizer/heat exchanger
   • Converts liquid oxygen to gas before it enters the pipeline
   • Usually an ambient-temperature vaporizer (coiled tubing exposed to outside air)
3. Pressure regulators
   • Reduce gas pressure to pipeline working pressure (~50 psig / 3.4 bar)
4. Backup supply
   • A smaller reserve LOx tank or bank of H-cylinders connected by manifold
   • Designed to provide 24 hours of oxygen requirements
   • Switches automatically if main supply fails
5. Alarm systems
   • Low-pressure alarms
   • Low-level alarms

The main supply source of oxygen in a large hospital usually is a cryogenic bulk oxygen storage system, refilled on site from a truck carrying liquid oxygen. Oxygen storage systems must have backup supply and alarm systems in place. - Miller's Anesthesia, 10e

---

Pipeline Delivery to the Operating Room

• LOx is vaporised and delivered through hospital pipeline at 50 psig (3.4 bar)
• Pipeline terminates at the operating room via DISS (Diameter Index Safety System) connectors - gas-specific and non-interchangeable
• The anaesthesia machine connects to this pipeline; a check valve prevents back-flow
• Colour coding: Green (USA) / White (International) for oxygen pipeline

---

Dewar Flask (Storage Vessel)

• Inner container (holds LOx)
• Outer container
• Interposed vacuum insulation layer
• Pressure-relief venting mechanism (mandatory - as LOx vaporises continuously, pressure rises)

---

Safety Considerations (High Yield for Exams)

Fire and Explosion Risk

• Oxygen is a powerful oxidiser - it does not burn itself but vigorously supports and accelerates combustion
• Any material that burns in air burns far more intensely in an oxygen-enriched atmosphere
• No smoking permitted within 25 feet of LOx storage
• LOx must be stored away from combustible materials and ignition sources

Cryogenic Burns/Frostbite

• Contact with LOx causes immediate cryogenic tissue injury (frostbite)
• Skin contact can cause freeze burns similar to dry ice

Explosion risk from spills

• A spill of LOx rapidly vaporises, creating an oxygen-enriched atmosphere that can cause ignition of normally non-flammable materials

Pipeline failure scenario

• In 2002, a faulty joint ruptured at the bottom of a cryogenic oxygen storage tank, releasing 8,000 gallons of LOx and compromising oxygen delivery to an entire medical centre. - Barash Clinical Anesthesia, 9e
• Anaesthesiologist's response to pipeline O₂ failure:
  1. Immediately turn on the backup E-cylinder on the anaesthesia machine
  2. Disconnect the pipeline supply (mandatory - because the machine preferentially uses the higher-pressure pipeline supply even if it contains the wrong gas or has failed)

Pressure-relief venting

• LOx continuously vaporises even with perfect insulation (Leidenfrost effect)
• Pressure-relief valves are mandatory - if venting is blocked, the vessel can explode
• Stored tanks must be vented outdoors

---

Comparison: LOx vs. Compressed Gas Cylinders

Note: Like nitrous oxide in cylinders, the pressure gauge does not accurately reflect the remaining liquid oxygen volume until all liquid has vaporised. Volume must be assessed by weighing the tank.

---

Oxygen Cylinder vs LOx: Key Facts to Remember

• E-cylinder: 625-700 L of O₂ at 1800-2200 psig; pressure falls proportionally as gas is used
• A full E-cylinder at 2000 psig = ~660 L; at 1000 psig ≈ half full ≈ 330 L; at 3 L/min flow, lasts ~110 min when half-full
• H-cylinder: 6000-8000 L of O₂
• LOx bulk tank: equivalent of many H-cylinders, refilled by truck

---

Anaesthesia-Specific Pearls

1. Always have a backup E-cylinder of oxygen available during every anaesthetic - even with bulk LOx pipeline supply, which can fail
2. The anaesthesia machine has a fail-safe valve (oxygen failure cutoff valve) that shuts off nitrous oxide if O₂ supply pressure drops - protects against hypoxic mixture delivery
3. Pipeline crossover (wrong gas in O₂ pipeline) is a rare but life-threatening hazard; an in-line oxygen analyser is the last line of defence
4. DISS connectors and Pin Index Safety System (PISS) are engineering safeguards against incorrect gas connections - but are not foolproof; always read tank labels
5. LOx is stored outside the hospital; the gas travels through an extensive pipeline, making it vulnerable to pipeline leaks, crossovers, and pressure drops

---

Summary Box (Exam Quick Revision)

• LOx = oxygen stored below -183°C in cryogenic Dewar vessels
• Critical temperature = -119°C (must store below this)
• Expansion ratio = 1:840 (1L liquid gives 840L gas)
• Pale blue in colour
• Hospital use: bulk cryogenic tank → vaporiser → pipeline (50 psig) → DISS connectors → anaesthesia machine
• Safety: fire/oxidiser risk, cryogenic burns, pressure-relief venting mandatory
• Backup: always have E-cylinder on anaesthesia machine
• Failure response: turn on cylinder, then disconnect pipeline

---

---

OXYGEN CONCENTRATORS, HYPERBARIC OXYGEN COMPLICATIONS & OXYGEN TOXICITY

Notes for MD Anaesthesia Examination

---

PART 1: OXYGEN CONCENTRATORS

Definition

---

Principle of Operation

1. Compression: An electric compressor draws in ambient air and compresses it
2. Heat exchange: Compressed air (heated by compression) passes through a heat exchanger to cool it
3. Molecular sieve beds: Air is passed through beds of zeolite crystals - granular particles that selectively adsorb nitrogen (and argon) based on their molecular properties, allowing oxygen to pass through
4. Cycling: Two sieve beds cycle alternately - while one is adsorbing nitrogen, the other is regenerating (by venting trapped nitrogen as waste)
5. Product tank: Concentrated oxygen collects in a reservoir tank, pressurised to ~10 psi, filtered through a bacteria filter, then delivered to the patient via a flow meter

Oxygen concentrators use a technique called pressure swing adsorption and zeolite crystals to extract nitrogen from the air to produce oxygen. - Miller's Anesthesia, 10e

---

Oxygen Purity (Output Concentration)

• Pure oxygen cylinders deliver 100% O₂ at any flow rate up to 6 L/min
• Only 2 of 8 concentrators in one performance study delivered >82% O₂ at 35°C and 50% relative humidity (Miller's)
• Output purity is NOT the same as piped hospital oxygen (100%) - this has anaesthetic implications

---

Types

1. Stationary/Large Concentrators

• Weigh ~35 lb (16 kg)
• Deliver up to 10 L/min
• Require humidification at high flow rates
• Tethered to power source
• Used in home oxygen therapy, wards, PACU in resource-limited settings

2. Portable Concentrators

• Weigh 5-10 lb (2.3-4.5 kg)
• Battery life ~2.5 hours
• Max flow typically ≤5 L/min
• Approved by FAA for use on aircraft
• Used for ambulatory oxygen therapy

---

Delivery Pressure Limitation (Critical for Anaesthesia)

• Most portable concentrators deliver oxygen at pressures far less than 3.4 bar (50 psi)
• Pipeline oxygen is delivered at 50 psi
• Therefore, oxygen concentrators cannot drive:
  • Ventilators without a built-in turbine or compressor
  • Anaesthesia machines that require pipeline pressure
  • Most pneumatically driven devices
• They can supply supplemental oxygen in:
  • Operating theatre (via drawover anaesthesia system)
  • PACU
  • Ward
• Higher flow rates can be achieved by combining multiple concentrators in parallel

---

Uses of Oxygen Concentrators

Clinical Uses

Specific Indications (LTOT Guidelines)

• PaO₂ ≤55 mmHg OR SpO₂ ≤88% at rest on room air
• PaO₂ 56-59 mmHg with cor pulmonale or polycythaemia
• Minimum prescription: 15 hours/day
• Target: Resting SpO₂ >90%
• Starting flow rate: 2 L/min (titrated)

---

Advantages

• No cylinders to refill - works as long as electricity is available
• Cost-effective for long-term use
• Compact and convenient for home use
• No high-pressure storage hazard
• Continuous supply (no "running out" as with cylinders)

Limitations

• Requires electricity - failure during power cuts (need backup cylinders)
• Purity drops at high flow rates
• Insufficient pressure to drive most ventilators/anaesthesia machines
• Not suitable for driving flow-dependent or pressure-dependent equipment
• Performance degrades in high temperatures and high humidity
• Require regular maintenance (filters, valves, compressors)
• Not all models conform to WHO guidelines

---

PART 2: HYPERBARIC OXYGEN (HBO) THERAPY AND ITS COMPLICATIONS

Definition

At sea level: PaO₂ breathing air ≈ 100 mmHg; breathing 100% O₂ at 3 ATA ≈ 2000+ mmHg

---

Types of Hyperbaric Chambers

Monoplace Chamber

• Accommodates one patient (or one tender + small child)
• Walls of Plexiglas - allows visual observation
• Compressed with 100% oxygen (chamber atmosphere is pure O₂)
• Limit: 3 ATA maximum
• Advantages: Lower cost, easier installation, can connect to hospital O₂ supply
• Limitations:
  • Patient not directly accessible
  • Emergency airway management impossible during treatment
  • Pneumothorax cannot be decompressed until chamber decompresses (potentially fatal tension pneumothorax)
  • Psychological aversion to confinement

Multiplace Chamber

• Accommodates multiple patients + medical staff (up to 12+ patients)
• Compressed with air; patients breathe 100% O₂ via mask, hood, or ETT
• Allows direct access to patients by nursing/medical personnel
• Monitoring and resuscitative procedures are straightforward
• More expensive, requires significant space
• Medical staff inside incur a decompression obligation (limiting treatment time)

---

Established Indications for HBOT

HBOT Indications for CO Poisoning Specifically:

• Loss of consciousness (even transient)
• Neurologic impairment (dizziness, confusion, headache)
• Cardiac abnormalities (ischaemia, arrhythmias, ventricular failure)
• Metabolic acidosis
• HbCO >25%
• Pregnancy with fetal distress
• Protocol: 2.8-3 ATA for 1-3 treatments or until clinically stable

---

COMPLICATIONS OF HYPERBARIC OXYGEN THERAPY

1. Oxygen Toxicity (CNS - Paul Bert Effect)

• Occurs when O₂ partial pressure exceeds 1.4-1.6 ATA
• Symptoms: Visual disturbances, tinnitus, nausea, facial twitching, grand mal seizure (most feared)
• Seizures can be fatal if patient is underwater (drowning risk in divers)
• Precipitants: Hyperthermia, CO₂ retention, exertion, hyperthyroidism
• Management: Air breaks (5-min air-breathing intervals), reduce O₂ partial pressure

2. Pulmonary Oxygen Toxicity (Lorrain Smith Effect)

• Occurs with prolonged high O₂ exposure
• Early: Tracheobronchitis - substernal burning chest pain, cough, tightness
• Progressive: Decreased vital capacity, decreased lung compliance
• Severe: ARDS-like picture
• Risk thresholds:
  • Onset after 12-16 h at 1 ATA
  • Onset after 8-14 h at 1.5 ATA
  • Onset after 3-6 h at 2 ATA
• Mitigation: "Air breaks" - 5-minute periods of air breathing interspersed during treatment to slow rate of pulmonary toxicity development

3. Ear and Sinus Barotrauma (Middle Ear/Sinus Squeeze)

• Most common complication of HBOT
• Caused by failure to equilibrate middle ear/sinus pressure during compression or decompression
• Presents as ear pain, fullness, hearing loss, tympanic membrane rupture
• Prevention: Valsalva manoeuvre, slow compression rate
• Contraindication: Recent ear surgery, perforated tympanic membrane (relative)

4. Dental Barotrauma (Barodontalgia)

• Pain in teeth with air-containing cavities during pressure changes
• Related to poorly restored cavities or recent dental work

5. Pulmonary Barotrauma

• Rare but life-threatening
• Gas trapping (e.g., emphysema, asthma, COPD) can lead to pneumothorax or tension pneumothorax during decompression
• In monoplace chambers: Tension pneumothorax cannot be treated until chamber decompresses - potentially fatal
• Requires chest drain insertion before treatment if significant bullous disease

6. Decompression Obligation for Attendants

• In multiplace chambers, medical staff breathing air at high pressure dissolve nitrogen into their tissues
• Must decompress slowly on exit - limits their ability to accompany critically ill patients for prolonged treatments

7. Fire/Explosion Risk

• 100% oxygen atmosphere in monoplace chambers is highly flammable
• Strict protocols: No petroleum products, no synthetic fibres, no electronic devices inside
• All equipment must be HBOT-compatible

8. Claustrophobia/Psychological Distress

• Confinement in the chamber causes distress in susceptible patients
• Limits treatment time in monoplace chambers

9. Visual Changes (Myopia)

• Transient myopia occurs with prolonged courses of HBOT
• Generally reverses within weeks of treatment cessation
• Mechanism: Lens changes from O₂-induced protein oxidation

10. Hypoglycaemia

• HBOT can precipitate hypoglycaemia in diabetic patients
• Blood glucose must be monitored before and after each session

11. Confinement/Isolation Issues

• Boredom, anxiety, and patient isolation are practical limiting factors for treatment schedules
• Particularly problematic for repeated or prolonged treatments

---

PART 3: OXYGEN TOXICITY

Historical Note

• 1775: Joseph Priestley (discoverer of oxygen) wrote that oxygen "might not be so proper for us in the usual healthy state of the body"
• 1899: J. Lorrain Smith first systematically described pulmonary O₂ toxicity in animals

---

Mechanism: Free Radical Injury

• Superoxide anion (O₂⁻)
• Hydrogen peroxide (H₂O₂)
• Hydroxyl radical (OH•) - most reactive
• Singlet oxygen (¹O₂)

• Lipid peroxidation → membrane dysfunction
• Protein oxidation → enzyme failure
• DNA/nucleic acid damage → mutagenesis, cell death

A vast body of evidence supports that O₂ toxicity is caused by the excessive production of oxygen-free radicals. At high O₂ partial pressures, scavenging mechanisms can be overcome by increased rates of free radical production. - Miller's Anesthesia, 10e

---

Pulmonary Oxygen Toxicity (Most Relevant Clinically)

Timing

• Subtle pulmonary function changes: 8-12 hours of 100% O₂
• Increased capillary permeability and decreased pulmonary function: after 18 hours
• Serious injury: Requires much longer exposure
• FiO₂ < 0.5 (50%): Generally considered safe long-term
• 100% O₂ for 10-20 hours: Generally considered safe
• FiO₂ > 50-60% for prolonged periods: Undesirable, risk of toxicity

Pathological Phases

• Death of alveolar Type I pneumocytes and capillary endothelial cells
• Interstitial oedema
• Exudative alveolar filling
• Neutrophil recruitment (capillaries → interstitium → alveoli)

• Proliferation of Type II pneumocytes (cover exposed basement membrane)
• Endothelial cell proliferation
• Fibroblast proliferation
• Recovery: Interstitial scarring, fairly normal appearing capillary endothelium and alveolar epithelium

Clinical Manifestations

1. Tracheobronchitis: Substernal chest pain, cough (earliest symptom)
2. Decreased vital capacity (VC)
3. Decreased diffusion capacity (DLCO)
4. Decreased lung compliance
5. Widening A-a gradient
6. Progressive ARDS picture
7. In neonates: Bronchopulmonary dysplasia (BPD)

Most Clinically Relevant Concerns (Exam Focus)

1. Absorption atelectasis
2. Hypercapnic respiratory failure in COPD patients (loss of hypoxic drive)
3. ARDS (with prolonged high FiO₂)
4. Hyaline membrane disease / Bronchopulmonary dysplasia in neonates

---

Absorption Atelectasis

• Occurs when high FiO₂ washes out nitrogen from poorly-ventilated alveoli
• Nitrogen normally acts as a "splint" keeping alveoli open (inert, cannot diffuse into blood)
• When nitrogen is replaced by oxygen, alveolar gas is absorbed into capillary blood
• Low V/Q segments collapse → intrapulmonary shunt → worsening hypoxaemia (paradoxical)
• Mathematically: Time to alveolar collapse after airway occlusion:
  • Breathing air (3 min preoxygenation): ~37 minutes
  • After preoxygenation with 100% O₂: ~8.7 minutes
• Clinical application: Using 30-40% O₂ during induction (rather than 100%) reduces post-induction atelectasis

---

CNS Oxygen Toxicity (Hyperbaric Conditions Only)

• Occurs at PO₂ > 1.4-1.6 ATA (not seen at 1 ATA)
• Symptoms: VENTID mnemonic:
  • Visual disturbances (tunnel vision)
  • Ear symptoms (tinnitus)
  • Nausea
  • Twitching (facial/lip muscles - early warning sign)
  • Irritability, anxiety
  • Dizziness → Grand mal seizure (most severe)
• Precipitating factors: CO₂ retention, hyperthermia, exertion, hyperthyroidism
• Rarely occurs at clinical HBOT pressures (2-3 ATA) with air breaks
• At 1 ATA: O₂ toxicity is almost exclusively pulmonary

---

Retinopathy of Prematurity (ROP)

• Neovascular retinal disorder in premature infants (especially <28 weeks gestation)
• Formerly called retrolental fibroplasia
• Risk factors: High FiO₂ (historically unmonitored), low birth weight, sepsis, prematurity
• Correlates with arterial (not alveolar) O₂ tension - contrast with pulmonary toxicity
• Recommended PaO₂ in premature infants: 50-80 mmHg (SpO₂ 88-95%)
• Does not mean withholding O₂ when cardiopulmonary indications exist

---

Hypoventilation from Supplemental O₂ (COPD)

• COPD patients with chronic CO₂ retention develop hypoxic ventilatory drive dependency
• Correcting hypoxaemia to normal levels removes this drive → severe hypoventilation
• Additionally: High O₂ in COPD causes V/Q mismatch worsening (Haldane effect)
• Use controlled low-flow O₂ (24-28% via Venturi mask) targeting SpO₂ 88-92%
• Pulse oximetry is a poor monitor for opioid-induced hypoventilation if supplemental O₂ is running - opioid-depressed ventilation may be masked

---

Summary Table: Oxygen Toxicity - Quick Revision

---

Anaesthesia-Specific Pearls (Exam Focus)

1. Pre-oxygenation debate: 100% O₂ for RSI vs. lower FiO₂ to reduce atelectasis - current evidence favours FiO₂ 0.8-1.0 for denitrogenation/apnoeic oxygenation safety margin despite some atelectasis risk
2. Oxygen concentrators deliver <50 psi - cannot drive standard anaesthesia machines; use only with drawover systems
3. HBOT chambers during anaesthesia: Drug dosing may be altered under pressure; pharmacodynamics can change
4. Neonatal anaesthesia: Target SpO₂ 88-95% in premature infants; avoid hyperoxia
5. Air breaks in HBOT: 5-minute air-breathing intervals reduce both CNS and pulmonary O₂ toxicity accumulation during prolonged HBO treatment schedules

---